Multidisciplinary guidelines for the management of community-acquired pneumonia;Guía multidisciplinar para la valoración pronóstica, diagnóstico y tratamiento de la neumonía adquirida en la comunidad

Medicina Clinica

Volumn 140, Issue 5, 2013, Pages

  Torres, Antoni ^a   Barberán, José ^a   Falguera, Miquel ^a   Menéndez, Rosario ^a   Molina, Jesús ^a   Olaechea, Pedro ^a   Rodríguez, Alejandro ^a  

^a NONE

Author keywords

Acquired pneumonia; Hospital admission; Infectious respiratory disease; Mortality

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; HEALTH CARE PERSONNEL; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MORTALITY; PRACTICE GUIDELINE; PROGNOSIS; TREATMENT FAILURE; COMMUNICABLE DISEASE; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; MICROBIOLOGY; PNEUMONIA; VACCINATION;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA; PROGNOSIS; VACCINATION;

EID: 84874760594     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2012.09.034     Document Type: Article

References (161)

1. T. Welte, A. Torres, and D. Nathwani Clinical and economic burden of community-acquired pneumonia among adults in Europe Thorax 67 2012 71 79
2. R. Ferrer, A. Artigas, M.M. Levy, J. Blanco, G. González- Díaz, and J. Garnacho-Montero Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain JAMA 299 2008 2294 2303
3. P.G. Dambrava, A. Torres, X. Vallès, J. Mensa, M.A. Marcos, and G. Peñarroja Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome Eur Respir J 32 2008 892 901
4. L.A. Mandell, R.G. Wunderink, A. Anzueto, J.G. Bartlett, G.D. Campbell, and N.C. Dean Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 Suppl. 2 2007 S27 S72
5. W.S. Lim, S.V. Baudouin, R.C. George, A.T. Hill, C. Jamieson, and I. le Jeune BTS guidelines for the management of community acquired pneumonia in adults: update 2009 Thorax 64 Suppl 3 2009 iii1 iii55
6. M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, and M. Leven Guidelines for the management of adult lower respiratory tract infections - summary Clin Microbiol Infect 17 Suppl 6 2011 1 24
7. R. Menéndez, A. Torres, J. Aspa, A. Capelastegui, C. Prat, and F.R. de Castro [Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR)] Arch Bronconeumol 46 2010 543 558
8. L.A. Rodriguez, A. Ruigómez, M.A. Walander, and S. Johansson Acid-suppressive drugs and community-acquired pneumonia Epidemiology 20 2009 800 806
9. T. Welte, and T. Kohnlein Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network Semin Respir Crit Care Med 30 2009 127 135
10. C. Jokinen, L. Heiskanen, H. Juvonen, S. Kallinen, K. Karkola, and M. Korppi Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland Am J Epidemiol 137 1993 977 988
11. J. Almirall, I. Morato, F. Riera, A. Verdaguer, R. Priu, and P. Coll Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study Eur Respir J 6 1993 14 18
12. A. Vila-Córcoles, O. Ochoa-Gondar, T. Rodríguez-Blanco, X. Raga-Luria, F. Gómez-Bertomeu EPIVAC Study Group Epidemiology of community-acquired pneumonia in older adults: a population-based study Respir Med 103 2009 309 316
13. O. Ochoa-Gondar, A. Vila-Córcoles, C. de Diego, V. Arija, M. Maxenchs, and M. Grive The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 study BMC Public Health 8 2008 222
14. M.S. Niederman Community-acquired pneumonia: the US perspective Semin Respir Crit Care Med 30 2009 179 188
15. A. Chacón García, A. Ruigómez, and L.A. García Rodríguez Incidencia de neumonía adquirida en la comunidad en la cohorte poblacional de la base de datos en atención primaria (BIFAP) Aten Primaria 42 2010 543 551
16. S.S. Jick, J.A. Kaye, C. Vasilakis-Scaramozza, L.A. García Rodríguez, A. Ruigómez, and C.R. Meier Validity of the general practice research database Pharmacotherapy 23 2003 686 689
17. M. Woodhead, C.A. Welch, D.A. Harrison, G. Bellingan, and G. Ayres Community-acquired pneumonia on the intensive care unit: secondary analysis of 17869 cases in the ICNARC Case Mix Programme Database Crit Care 10 Suppl 2 2006 S1
18. S. Ewig, N. Birkner, R. Strauss, E. Schaefer, J. Pauletzky, and H. Bischoff Mew perspectives on community-acquired pneumonia in 388406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality Thorax 64 2009 1062 1069
19. C.L. Totter, J.M. Stuart, R. George, and E. Miller Increasing hospital admissions for pneumonia, England Emerg Infect Dis 14 2008 727 733
20. E.M. Mortensen, W.N. Kapoor, C.C. Chang, and M.J. Fine Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia Clin Infect Dis 37 2003 1617 1624
21. C. Cillóniz, S. Ewing, E. Polverino, M.A. Marcos, C. Esquinas, and A. Gabarrús Microbial aetiology of community-acquired pneumonia and its relation to severity Thorax 66 2011 340 346
22. M. Falguera, J. Carratalà, A. Ruiz-Gonzalez, C. García-Vidal, I. Gazquez, and J. Dorca Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli Respirology 14 2009 105 111
23. A.J. Kallen, J. Brunkard, Z. Moore, P. Budge, K.E. Arnold, and G. Fosheim Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season Ann Emerg Med 53 2009 358 365
24. H. Von Baum, T. Welte, R. Marre, N. Suttorp, C. Lück, and S. Ewig Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for community-acquired pneumonia (CAPNETZ) BMC Infect Dis 9 2009 62
25. E. Pérez-Trallero, J.E. Martín-Herrero, A. Mazón, C. García-Delafuente, P. Robles, and V. Iriarte Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007) Antimicrob Agents Chemother 54 2010 2953 2959
26. J.P. Metlay, and M.J. Fine Testing strategies in the initial management of patients with community-acquired pneumonia Ann Intern Med 138 2003 109 118
27. W.T. O'Brien Sr., D.A. Rohweder, G.E. Lattin Jr., J.A. Thornton, J.P. Dutton, and D.L. Ebert-Long Clinical indicators of radiographic findings in patients with suspected community-acquired pneumonia: who needs a chest x-ray? J Am Coll Radiol 3 2006 703 706
28. R. Menéndez, M. Cavalcanti, S. Reyes, J. Mensa, R. Martínez, and M.A. Marcos Markers of treatment failure in hospitalised community acquired pneumonia Thorax 63 2008 447 452
29. D.T. Huang, L.A. Weissfeld, J.A. Kellum, D.M. Yealy, L. Kong, and M. Martino Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia Ann Emerg Med 52 2008 48 58
30. R. Menéndez, J.M. Sahuquillo Arce, S. Reyes, R. Martínez, E. Polverino, and C. Cillóniz Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia Chest 141 2012 1537 1545
31. J. Steurer, U. Held, A. Spaar, B. Bausch, M. Zoller, and R. Hunziker A decision aid to rule out pneumonia and reduce unnecessary prescriptions of antibiotics in primary care patients with cough and fever BMC Med 9 2011 56
32. B.M. Farr, D.L. Kaiser, B.D. Harrison, and C.K. Connolly Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee Thorax 44 1989 1031 1035
33. P. Moine, J.B. Vercken, S. Chevret, C. Chastang, and P. Gajdos Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit Chest 105 1994 1487 1495
34. T.J. Marrie Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly Arch Intern Med 153 1993 488 494
35. C.M. Helms, L.A. Wintermeyer, R.R. Zeitler, R.E. Larew, R.M. Massanari, and N.H. Hall An outbreak of community-acquired Legionnaires' disease pneumonia Am J Public Health 74 1984 835 836
36. A. Granados, D. Podzamczer, F. Gudiol, and F. Manresa Pneumonia due to Legionella pneumophila and pneumococcal pneumonia: similarities and differences on presentation Eur Respir J 2 1989 130 134
37. D. Lieberman, A. Porath, F. Schlaeffer, D. Lieberman, and I. Boldur Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients Chest 109 1996 1243 1249
38. V. Falcó, T. Fernández de Sevilla, J. Alegre, A. Ferrer, and J.M. Martínez Vázquez Legionella pneumophila. A cause of severe community-acquired pneumonia Chest 100 1991 1007 1011
39. N. Sopena, M. Sabriá-Leal, M.L. Pedro-Botet, E. Padilla, J. Dominguez, and J. Morera Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias Chest 113 1998 1195 1200
40. N. Fernández-Sabé, B. Rosón, J. Carratalà, J. Dorca, F. Manresa, and F. Gudiol Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system Clin Infect Dis 37 2003 483 489
41. F. Caron, J.C. Meurice, P. Ingrand, A. Bourgoin, P. Masson, and P. Roblot Acute Q fever pneumonia: a review of 80 hospitalized patients Chest 114 1998 808 813
42. V. Sobradillo, P. Ansola, F. Baranda, and C. Corral Q fever pneumonia: a review of 164 community-acquired cases in the Basque country Eur Respir J 2 1989 263 266
43. D. Lieberman, D. Lieberman, I. Boldur, E. Manor, S. Hoffman, and F. Schlaeffer Q-fever pneumonia in the Negev region of Israel: a review of 20 patients hospitalised over a period of one year J Infect 30 1995 135 140
44. F. Arancibia, T.T. Bauer, S. Ewig, J. Mensa, J. González, and M.S. Niederman Community-acquired pneumonia due to Gram-negative bacteria and Pseudomonas aeruginosa Arch Intern Med 162 2002 1849 1858
45. K.P. Levin, B.H. Hanusa, A. Rotondi, D.E. Singer, C.M. Coley, and T.J. Marrie Arterial blood gas and pulse oximetry in initial management of patients with community-acquired pneumonia J Gen Intern Med 16 2001 590 598
46. W.G. Boersma, J.M. Daniels, A. Löwenberg, W.J. Boeve, and E.J. van de Jagt Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia Respir Med 100 2006 926 932
47. J.T. MacFarlane, A.C. Miller, W.H. Roderick Smith, A.H. Morris, and D.H. Rose Comparative radiographic features of community acquired Legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia and psittacosis Thorax 39 1984 28 33
48. J. Macfarlane, and D. Rose Radiographic features of staphylococcal pneumonia in adults and children Thorax 51 1996 539 540
49. H. Syrjala, M. Broas, I. Suramo, A. Ojala, and S. Lahde High-resolution computed tomography for the diagnosis of community-acquired pneumonia Clin Infect Dis 27 1998 358 363
50. W.W. Reed, G.S. Byrd, R.H. Gates Jr., R.S. Howard, and M.J. Weaver Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis West J Med 165 1996 197 204
51. E. Garcia-Vazquez, M.A. Marcos, J. Mensa, A. de Roux, J. Puig, and C. Font Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system Arch Intern Med 164 2004 1807 1811
52. N. Miyashita, H. Shimizu, K. Ouchi, K. Kawasaki, Y. Kawai, and Y. Obase Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization Med Sci Monit 14 2008 CR171 CR176
53. D.M. Musher, R. Montoya, and A. Wanahita Diagnostic value of microscopio examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia Clin Infect Dis 39 2004 165 169
54. S. Anevlavis, N. Petroglou, A. Tzavaras, E. Maltezos, I. Pneumatikos, and M. Froudarakis A prospective study of the diagnostic utility of sputum Gram stain in pneumonia J Infect 59 2009 83 89
55. R. Theerthakarai, W. el-Halees, M. Ismail, R.A. Solis, and M.A. Khan Nonvalue of the inicial microbiological studies in the management of nonsevere community-acquired pneumonia Chest 119 2001 181 184
56. M.M. Van der Eerden, F. Vlaspolder, C.S. de Graaff, T. Groot, H.M. Jansen, and W.G. Boersma Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia Eur J Clin Microbiol Infect Dis 24 2005 241 249
57. E. Manali, A. Papadopoulos, S. Tsiodras, V. Polychronopoulos, H. Giamarellou, and K. Kanellakopoulo The impact on community-acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques Scand J Infect Dis 40 2008 286 292
58. G.W. Waterer, and R.G. Wunderink The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures Respir Med 95 2001 78 82
59. S.G. Campbell, T.J. Marrie, R. Anstey, G. Dickinson, and S. Ackroyd-Stolarz The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study Chest 123 2003 1142 1150
60. N. Afshar, J. Tabas, K. Afshar, and R. Silbergleit Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review J Hosp Med 4 2009 112 123
61. M. Falguera, J. Trujillano, S. Caro, R. Menéndez, J. Carratalà, and A. Ruiz-González A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia Clin Infect Dis 49 2009 409 416
62. C.L. Sheppard, T.G. Harrison, A.M. Kearns, M. Guiver, M. Creek, and S. Evans Diagnosis of invasive pneumococcal infection by PCR amplification of Streptococcus pneumoniae genomic fragments in blood: a multi-centre comparative study Commun Dis Public Health 6 2003 221 227
63. H. Von Baum, S. Ewig, R. Marre, N. Suttorp, S. Gonschior, and T. Welte Community-acquired Legionella pneumonia: new insights from the German competence network for community-acquired pneumonia Clin Infect Dis 46 2008 1356 1364
64. F. Gutiérrez, M. Masiá, J.C. Rodríguez, A. Ayelo, B. Soldán, and L. Cebrián Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain Clin Infect Dis 36 2003 286 292
65. T. Ishida, T. Hashimoto, M. Arita, Y. Tojo, H. Tachibana, and M. Jinnai A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology J Infect Chemother 10 2004 359 363
66. M.A. Marcos, M.T. Jiménez de Anta, J.P. de la Bellacasa, J. González, E. Martínez, and E. García Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults Eur Respir J 21 2003 209 214
67. J. Dominguez, N. Gali, S. Blanco, P. Pedroso, C. Prat, and L. Matas Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples Chest 119 2001 243 249
68. D.R. Murdoch, R.T. Laing, G.D. Mills, N.C. Karalus, G.I. Town, and S. Mirrett Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia J Clin Microbiol 39 2001 3495 3498
69. M. Falguera, A. Ruiz-González, J.A. Schoenenberger, C. Touzón, I. Gázquez, and C. Galindo Prospective, randomized study to compare empirical treatment versus targeted treatment on the basis of the antigen urine results on hospitalised patients with commnuity-acquired pneumonia Thorax 65 2010 101 106
70. R. Sordé, V. Falcó, M. Lowak, E. Domingo, A. Ferrer, and J. Burgos Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy Arch Intern Med 171 2011 166 172
71. H. Oka, A. Ueda, Y. Watanuki, J. Tsukiji, H. Kuroda, and H. Akashi The efficacy of high-dose penicillin for community-acquired pneumonia diagnosed by pneumococcal urine antigen test J Infect Chemother 15 2009 108 112
72. R.J. Birtles, T.G. Harrison, D. Samuel, and A.G. Taylor Evaluation of urinary antigen ELISA for diagnosing Legionella pneumophila serogroup 1 infection J Clin Pathol 43 1990 685 690
73. J.H. Helbig, S.A. Uldum, P.C. Lück, and T.G. Harrison Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urin Antigen EIA J Med Microbiol 50 2001 509 516
74. M.F. Beersma, K. Dirven, A.P. van Dam, K.E. Templeton, E.C. Claas, and H. Goossens Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard" J Clin Microbiol 43 2005 2277 2285
75. M.J. Fine, T.E. Auble, D.M. Yealy, B.H. Hanusa, L.A. Weissfeld, and D.E. Singer A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 1997 243 250
76. W.S. Lim, J.T. Macfarlane, T.C. Boswell, T.G. Harrison, D. Rose, and M. Leinonen Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines Thorax 56 2001 296 301
77. British Thoracic Society Research Committee Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors, and outcome Q J Med 62 1987 195 220
78. A. Capelastegui, P.P. España, J.M. Quintana, I. Areitio, I. Gorordo, and M. Egurrola Validation of a predictive rule for the management of community-acquired pneumonia Eur Respir J 27 2006 151 157
79. W.S. Lim, M.M. van der Eerden, R. Laing, W.G. Boersma, N. Karalus, and G.I. Town Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 2003 377 382
80. W.S. Lim, S. Lewis, and J.T. Macfarlane Severity prediction rules in community acquired pneumonia: a validation study Thorax 55 2000 219 223
81. S. Ewig, A. de Roux, T. Bauer, E. García, J. Mensa, and M. Niederman Validation of predictive rules and indices of severity for community-acquired pneumonia Thorax 59 2004 421 427
82. J. Rello, A. Rodriguez, A. Torres, J. Roig, J. Sole-Violan, and Garnacho-Montero Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia Eur Respir J 27 2006 1210 1216
83. M.I. Restrepo, E.M. Mortensen, J.A. Pugh, and A. Anzueto COPD is associated with increased mortality in patients with community-acquired pneumonia Eur Respir J 28 2006 346 351
84. A. Vila-Corcoles, O. Ochoa-Gondar, and T. Rodríguez-Blanco Utilidad de la escala CRB-65 en la evaluación pronóstica de los pacientes mayores de 65 años con neumonía adquirida en la comunidad Med Clin (Barc) 19 2010 97 102
85. F.W. Arnold, J.A. Ramírez, L.C. McDonald, E.L. Xia, P.P. España, and A. Capelastegui Hospitalization for community-acquired pneumonia: the pneumonia severity index versus clinical judgment. A prediction rule to identify allocation of inpatient care in community-acquired pneumonia Chest 124 2003 121 124
86. P.P. España, A. Capelastegui, J.M. Quintana, A. Soto, I. Gorordo, and M. García-Urbaneja A prediction rule to identify allocation of inpatient care in community-acquired pneumonia Eur Respir J 21 2003 695 701
87. S.I. Blot, A. Rodríguez, J. Solé-Violán, J. Blanquer, J. Almirall, and J. Rello Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia Crit Care Med 35 2007 2509 2514
88. D. Aujesky, T.E. Auble, D.M. Yealy, R.A. Stone, D.S. Obrosky, and T.P. Meehan Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia Am J Med 118 2005 384 392
89. J.D. Chalmers, P. Mandal, A. Singanayagam, A.R. Akram, G. Choudhury, and P.M. Short Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis Intensive Care Med 37 2011 1409 1420
90. S.M. Brown, and N.C. Dean Defining severe pneumonia Clin Chest Med 32 2011 469 479
91. S. Ewig, M. Woodhead, and A. Torres Towards a sensible comprehension of severe community-acquired pneumonia Intensive Care Med 37 2011 214 223
92. J. Phua, W.J. Ngerng, and T.K. Lim The impact of a delay in intensive care unit admission for community-acquired pneumonia Eur Respir J 36 2010 826 833
93. M.I. Restrepo, E.M. Mortensen, J. Rello, J. Brody, and A. Anzueto Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality Chest 137 2010 522 527
94. M.S. Niederman, L.A. Mandell, A. Anzueto, J.B. Bass, W.A. Broughton, and G.D. Campbell Society American Thoracic Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention Am J Respir Crit Care Med 163 2001 1730 1754
95. A. Liapikou, M. Ferrer, E. Polverino, V. Balasso, M. Esperatti, and R. Piñer Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission Clin Infect Dis 48 2009 377 385
96. S.M. Brown, B.E. Jones, A.R. Jephson, and N.C. Dean Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia Crit Care Med 37 2009 3010 3016
97. J. Phua, K.C. See, Y.H. Chan, L.S. Widjaja, N.W. Aung, and W.J. Ngerng Validation and clinical implications of implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia Thorax 64 2009 598 603
98. J.D. Chalmers, J.K. Taylor, P. Mandal, G. Choudhury, A. Singanayagam, and A.R. Akram Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care Clin Infect Dis 53 2011 503 511
99. E.M. Mortensen, S. Garcia, L. Leykum, B. Nakashima, M.I. Restrepo, and A. Anzueto Association of hypoglycemia with mortality for subjects hospitalized with pneumonia Am J Med Sci 339 2010 239 243
100. J.M. Gamble, D.T. Eurich, T.J. Marrie, and S.R. Majumdar Admission hypoglycemia and increased mortality in patients hospitalized with pneumonia Am J Med 123 2010 556.e11 556.e16
101. P.P. España, A. Capelastegui, I. Gorordo, C. Esteban, M. Oribe, and M. Ortega Development and validation of a clinical prediction rule for severe community-acquired pneumonia Am J Respir Crit Care Med 174 2006 1249 1256
102. P.P. Yandiola, A. Capelastegui, J. Quintana, R. Diez, I. Gorordo, and A. Bilbao Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia Chest 135 2009 1572 1579
103. P.G. Charles, R. Wolfe, M. Whitby, M.J. Fine, A.J. Fuller, R. Stirling Australian Community-Acquired Pneumonia Study Collaboration SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community acquired pneumonia Clin Infect Dis 47 2008 375 384
104. B. Renaud, J. Labarère, E. Coma, A. Santin, J. Hayon, and M. Gurgui Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community acquired pneumonia: development of an international prediction rule Crit Care 13 2009 R54
105. J. Rello, A. Rodriguez, T. Lisboa, M. Gallego, M. Lujan, and R. Wunderink PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia Crit Care Med 37 2009 456 462
106. P. Ramírez, M. Ferrer, V. Martí, S. Reyes, R. Martínez, and R. Menéndez Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia Crit Care Med 39 2011 2211 2217
107. Grupo de Estudio de la Neumonía Adquirida en la Comunidad. Área de Tuberculosis e Infecciones Respiratorias (TIR)-SEPAR Normativas para el diagnóstico y el tratamiento de la neumonía adquirida en la comunidad. Sociedad Española de Neumología y Cirugía Torácica (SEPAR) Arch Bronconeumol 41 2005 272 289
108. J. Carratalà, N. Fernández-Sabé, L. Ortega, X. Castellsaqué, B. Rosón, and J. Dorca Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients Ann Intern Med 142 2005 165 172
109. N. Daneman, A. McGeer, K. Green, and D.E. Low Macrolide resistance in bacteremic pneumococcal disease: implications for patient management Clin Infect Dis 43 2006 432 438
110. R. El Moussaoui, C.A. de Borgie, P. van den Broek, W.N. Hustinx, P. Bresser, and G.E. van der Berk Effectiveness of discontinuing antibiotic treatment after three days versus eight in mild to moderate-severe community adquired pneumonia: randomised, double blind study BMJ 332 2006 1355
111. A. Torres, J. Garau, P. Arvis, J. Carlet, S. Choudhri, and A. Kureishi Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study - a randomized clinical trial Clin Infect Dis 46 2008 1499 1509
112. J.A. Martínez, J.P. Horcajada, M. Almela, F. Marco, A. Soriano, and E. García Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia Clin Infect Dis 36 2003 389 395
113. L.M. Baddour, V.L. Yu, K.P. Klugman, C. Feldman, A. Ortqvist, and J. Rello Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia Am Respir Crit Care Med 170 2004 440 444
114. I. Martin-Loeches, T. Lisboa, A. Rodriguez, C. Putensen, D. Annane, and J. Garnacho-Montero Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia Intensive Care Med 36 2010 612 620
115. O. Leroy, P. Saux, J.P. Bédos, and E. Caulin Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors Chest 128 2005 172 183
116. S. Aliberti, A.M. Zanaboni, and F. Blasi Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores Clin Infect Dis 54 2012 1519 1520
117. H. Von Baum, T. Welte, R. Marre, N. Suttorp, and S. Ewig Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors Eur Respir J 35 2010 598 615
118. E.A. Halm, and A.S. Teirstein Clinical practice. Management of community-acquired pneumonia N Engl J Med 347 2002 2039 2045
119. P.M. Houck, D.W. Bratzler, W. Nsa, A. Ma, and J.G. Bartlett Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia Arch Intern Med 164 2004 637 644
120. M. Ferrer, M. Valencia, J.M. Nicolas, O. Bernadich, J.R. Badia, and A. Torres Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial Am J Respir Crit Care Med 173 2006 164 170
121. J.M. Pines, J.A. Isserman, and P.B. Hinfey The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine J Emerg Med 37 2009 335 340
122. R. Menendez, and A. Torres Treatment failure in community-acquired pneumonia Chest 132 2007 1348 1355
123. B. Rosón, J. Carratalà, N. Fernández-Sabé, F. Tubau, F. Manresa, and F. Gudiol Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia Arch Intern Med 164 2004 502 508
124. J.D. Chalmers, A. Singanayagam, and A.T. Hill Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia Clin Infect Dis 47 2008 1571 1574
125. E.A. Halm, M.J. Fine, T.J. Marrie, C.M. Coley, W.N. Kapoor, and D.S. Obrosky Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines JAMA 279 1998 1452 1457
126. S. Aliberti, A. Amir, P. Peyrani, M. Mirsaeidi, M. Allen, and B.K. Moffett Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia Chest 134 2008 955 962
127. X. Ye, V. Sikirica, J.R. Schein, R. Grant, V. Zarotsky, and D. Doshi Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis Clin Ther 30 2008 358 371
128. J.D. Chalmers, A. Singanayagam, and A.T. Hill C-reactive protein is an independent predictor of severity in community-acquired pneumonia Am J Med 121 2008 219 225
129. A.H. Bruns, J.J. Oosterheert, E. Hak, and A.I. Hoepelman Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia Eur Respir J 32 2008 726 732
130. U. Hohenthal, S. Hurme, H. Helenius, M. Heiro, O. Meurman, and J. Nikoskelainen Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia Clin Microbiol Infect 15 2009 1026 1032
131. R. Menéndez, R. Martinez, S. Reyes, J. Mensa, E. Polverino, and X. Filella Stability in community-acquired pneumonia: ne step forward with markers? Thorax 64 2009 987 992
132. A. Ruiz-Gonzalez, M. Falguera, J.M. Porcel, M. Martinez-Alonso, P. Cabezas, and P. Geijo C-reactive protein for discriminating treatment failure from slow responding pneumonia Eur J Intern Med 21 2010 548 552
133. F. Arancibia, S. Ewig, J.A. Martinez, M. Ruiz, T. Bauer, and M.A. Marcos Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications Am J Respir Crit Care Med 162 2000 154 160
134. J.A. Jacobs, E.I. de Brauwer, G. Ramsay, N.A. Cobben, S.S. Wagenaar, and A.J. van der Ven Detection of non-infectious conditions mimicking pneumonia in the intensive care setting: usefulness of bronchoalveolar fluid cytology Respir Med 93 1999 571 578
135. R. Menendez, A. Torres, R. Zalacain, J. Aspa, J.J. Martin Villasclaras, and L. Borderias Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome Thorax 59 2004 960 965
136. A.A. El-Solh, A.T. Aquilina, R.S. Dhillon, F. Ramadan, P. Nowak, and J. Davies Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia Am J Respir Crit Care Med 166 2002 1038 1043
137. T. Franquet Imaging of pneumonia: trends and algorithms Eur Respir J 18 2001 196 208
138. S.A. Moberley, J. Holden, D.P. Tatham, and R.M. Andrews Vaccines for preventing pneumococcal infection in adults Cochrane Database Syst Rev 23 2008 CD000422
139. D.N. Fisman, E. Abrutyn, K.A. Spaude, A. Kim, C. Kirchner, and J. Daley Prior pneumococcal vaccination is associated with reduced death, complications and length of stay among hospitalized adults with community-acquired pneumonia Clin Infect Dis 42 2006 1093 1101
140. A. Mykietiuk, J. Carratalà, A. Domínguez, A. Manzur, N. Fernández-Sabé, and J. Dorca Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia Eur J Clin Microbiol Infect Dis 25 2006 457 462
141. J. Johnstone, T.J. Marrie, D.T. Eurich, and S.R. Majumdar Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia Arch Intern Med 167 2007 1938 1943
142. L.A. Jackson, P. Benson, V.P. Sneller, J.C. Butler, R.S. Thompson, and R.T. Chen Safety of revaccination with pneumococcal polysaccharide vaccine JAMA 281 1999 243 248
143. K.A. Poehling, T.R. Talbot, M.R. Griffin, A.S. Craig, C.G. Whitney, and E. Zell Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine JAMA 295 2006 1668 1674
144. C.A. Lexau, R. Lynfield, R. Danila, T. Pilishvili, R. Facklam, and M.M. Farley Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine JAMA 294 2005 2043 2051
145. A. De Roux, B. Schmöele-Thoma, G.R. Siber, J.G. Hackell, A. Kuhnke, and N. Ahlers Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory Clin Infect Dis 46 2008 1015 1023
146. Moore M, Link-Gelles R, Farley M, Schaffner W, Thomas A, Reingold A, et al. Impact of 13-valent pneumococcal conjugate vaccine (PCV13) on invasive pneumococcal disease (IPD), U.S., 2010-11. 8th International Symposium on Pneumococci and Pneumococcal Diseases, Brazil, 11-15 March, 2012. Poster No 179.Diseases, Brazil, 11-15 March, 2012. Poster No 189.
147. Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, García de Miguel MJ, Hernández-Sampelayo T, et al., on behalf the HERACLES Study Group. First impact data of 13-valent pneumococcal conjugate vaccine (PCV13) on invasive pneumocococcaldisease in children in Madrid, 2010-2011 (HERACLES study). 8th International Symposium on Pneumococci and PneumococcalDiseases, Brazil, 11-15 March, 2012. Poster No 189.
148. Protocolos de la SEMPHSPH. Recomendaciones de vacunación antineumocócica en el adulto por indicación médica. Disponible en: http://www.sempsph.com/sempsph/index.php.
149. Centers for Disease Control and Prevention Prevention of pneumococcal disease among infants and children-Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine.Recommendations of the Advisory Committee on Immmunization Practices (ACIP) MMRW 59 RR-11 2010 1 19
150. Centers for Disease Control and Prevention Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: Recommendations of the Advisory Committee on Immmunization Practices (ACIP) MMRW 61 2012 816 819
151. S. Jain, and S.S. Chaves Obesity and influenza Clin Infect Dis 53 2011 422 424
152. D.N. Juurlink, T.A. Stukel, J. Kwong, A. Kopp, A. McGeer, and R.E. Upshur Guillain-Barré syndrome after influenza vaccination in adults Arch Intern Med 166 2006 2217 2221
153. K.L. Nichol, J.D. Nordin, D.B. Nelson, J.P. Mullooly, and E. Hak Effectiveness of influenza vaccine in the community-dwelling elderly N Engl J Med 357 2007 1373 1381
154. M.L. Jackson, J.C. Nelson, N.S. Weiss, K.M. Neuzil, W. Barlow, and L.A. Jackson Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study Lancet 372 2008 398 405
155. A. Manzur, C. Izquierdo, L. Ruiz, D. Sousa, J.M. Bayas, and J.M. Celorrio Influence of prior pneumococcal and influenza vaccination on outcomes of older adults with community-acquired pneumonia J Am Geriatr Soc 59 2011 1711 1716
156. D.T. Eurich, T.J. Marrie, J. Johnstone, and S.R. Majumdar Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding? Am J Respir Crit Care Med 178 2008 527 533
157. K.A. Spaude, E. Abrutyn, C. Kirchner, A. Kim, J. Daley, and D.N. Fisman Influenza vaccination and risk of mortality among adults hospitalized with community-acquired pneumonia Arch Intern Med 167 2007 53 59
158. J. Almirall, J. Bolíbar, M. Serra-Prat, J. Roig, I. Hospital, and E. Carandell New evidence of risk factors for community-acquired pneumonia: a population-based study Eur Respir J 31 2008 1274 1284
159. I. Baik, G.C. Curhan, E.B. Rimm, A. Bendich, W.C. Willett, and W.W. Fawci A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women Arch Intern Med 160 2000 3082 3088
160. P. Nuorti, J. Butler, M.M. Farley, L.H. Harrison, A. McGeer, and M.S. Kolczak Cigarette smoking and invasive pneumococcal disease N Engl J Med 342 2000 681 689
161. R. Libster, and K.M. Edwards How can we best prevente pertussis in infants? Clin Infect Dis 54 2012 85 87